Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Bullboard Posts
Post by NewFanCBDon Jun 24, 2020 9:31am
192 Views
Post# 31185035

Ignore this teenage shorter > Watch CRDL closely

Ignore this teenage shorter > Watch CRDL closely

Ignore The shorts here, along with their aliases, as they are going to be royally screwed if they play with this company. I believe Cardiol is inches away from doing something very special with their technologies to reduce symptoms of COVID-19 related to the swelling of the heart. If and when the company puts out news, the stock could triple.

This is a very special company that will continue to Get noticed in the medical and private consumer space as time goes on. Purity is where it's at, and customers will be looking for this.

Not concerned about the shoppers drug Mart issue that is mentioned here, I personally think shoppers was receiving too many inquiries about the product. The revenues here along with Europe and South America, make this a very special situation.

This stock is about to rock so keep it on your radar's.

Bullboard Posts